Estimating the effect of realistic improvements of metformin adherence on COVID-19 mortality using targeted machine learning
Background: Type 2 diabetes elevates the risk of severe outcomes in COVID-19 patients, with multiple studies reporting higher case fatality rates. Metformin is a widely used medication for glycemic management. We hypothesize that improved adherence to metformin may lower COVID-19 post-infection mort...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-06-01
|
Series: | Global Epidemiology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590113324000087 |